Camden Capital, LLC Corcept Therapeutics Inc Transaction History
Camden Capital, LLC
- $916 Million
- Q1 2025
A detailed history of Camden Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Camden Capital, LLC holds 2,581 shares of CORT stock, worth $198,143. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,581
Previous 4,053
36.32%
Holding current value
$198,143
Previous $204,000
44.12%
% of portfolio
0.03%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.27 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$766 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$594 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$472 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$305 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.22B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...